This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bracco Diagnostics Inc., E-Z-Em, Inc.. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Jorg F Debatin: Innovator in Medical Formulations
Introduction
Jorg F Debatin is a notable inventor based in Essen, Germany. He has made significant contributions to the field of medical and diagnostic formulations. With a total of 2 patents, his work focuses on enhancing medical procedures through innovative formulations.
Latest Patents
Debatin's latest patents involve formulations for use in medical and diagnostic procedures. These formulations comprise a stabilizing agent, which can be used alone or in combination with an osmotic agent. In one embodiment, the stabilizing agent is a natural hydrocolloid, preferably locust bean gum, while the osmotic agent is a sugar-based compound, preferably mannitol. His inventions also relate to methods for distending an anatomic segment and delineating it on diagnostic images. These formulations are particularly suitable for use with various diagnostic imaging procedures, including magnetic resonance imaging (MR), computer-assisted tomography (CT), and CT-PET (position emission tomography), as well as other medical and therapeutic applications.
Career Highlights
Throughout his career, Jorg F Debatin has worked with prominent companies in the medical field, including E-Z-Em, Inc. and Bracco Diagnostics Inc. His experience in these organizations has contributed to his expertise in developing innovative medical formulations.
Collaborations
Debatin has collaborated with notable professionals in his field, including Thomas C Lauenstein and Hubert Schneeman. These collaborations have further enriched his work and contributed to advancements in medical diagnostics.
Conclusion
Jorg F Debatin is a distinguished inventor whose work in medical formulations has the potential to significantly impact diagnostic procedures. His innovative approaches continue to pave the way for advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
